Glaukos Corporation Receives 510(K) Clearance from the U.S. Food and Drug Administration for the iPRIME

Glaukos Corporation announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iPRIME Viscodelivery System, a sterile, single-use, minimally-invasive device for the delivery of viscoelastic fluid during ophthalmic surgery.